Should we shift warfarin to non-vitamin K antagonist oral anticoagulants for patients with atrial fibrillation staying well on warfarin for years?

Back

EHRA Premium Access

Should we shift warfarin to non-vitamin K antagonist oral anticoagulants for patients with atrial fibrillation staying well on warfarin for years?

Session: Atrial Fibrillation - Round 2 - Stroke, ACO

Topic: Oral Anticoagulation

Speaker: Professor G. Lip (Liverpool, GB)

Event: EHRA 2023

Congress Presentation

Add to my library

About the speaker

Professor Gregory Yh Lip

University of Liverpool, Liverpool (United Kingdom of Great Britain & Northern Ireland)

100 presentations

9 followers

5 more presentations in this session

Racial differences in atrial fibrillation-related strokes and mortality.

Speaker: Doctor K. Dongseon (Seoul, KR)

Omitting transesophageal echocardiography before catheter ablation of atrial fibrillation or left sided atrial tachycardia in patients on oral anticoagulation.

Speaker: Mrs V. Maslova (Kiel, DE)

Cerebral microembolic signal burden during pulsed field ablation: preliminary results from robotically-assisted transcranial doppler and magnetic resonance imaging

Speaker: Doctor D. Della Rocca (Brussels, BE)

Clinical markers of atrial abnormality as predictors of cardioembolic events in patients with embolic stroke of undetermined source.

Speaker: Doctor J. Guichard (Barcelona, ES)

The association of P-terminal force value and increased risk for ischemic stroke among admitted patients in a tertiary hospital: a retrospective case-control study

Speaker: Doctor M. Manalili (San Juan, PH)

Access the full session

Atrial Fibrillation - Round 2 - Stroke, ACO

Speakers: Professor G. Lip, Doctor K. Dongseon, Mrs V. Maslova, Doctor D. Della Rocca, Doctor J. Guichard...

Access

Video

About the event

EHRA 2023

16 April - 18 April 2023

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources